We found that in these TNF/IL1-expressing AML cells, as is the case with inactivation of JNK signaling, inhibition of both IL1 and TNF represses growth and significantly sensitizes clonogenic LPs and leukemogenic LSCs to NF-κB inhibitor treatment. The gene discussed is IL1A; the disease is acute myeloid leukemia.